Oxford launches COVID reinfection study
To try and understand the immune response to SARS-CoV-2, including the threat of COVID reinfection, the University of Oxford will purposely infect volunteers.
All adults in the US are now eligible for COVID-19 vaccines
In the U.S., anyone over the age of 16 is now eligible for COVID-19 vaccines — a major milestone along the path to herd immunity.
Inhaled asthma drug accelerates COVID-19 recovery at home
Budesonide — a cheap, inhaled asthma drug that can be self-administered — appears to shorten at-risk COVID-19 patients’ recovery times.
Hologram pizzeria brings virtual happy hour to a new level
Virgin Media’s hologram dining experience, Two Hearts Pizzeria, let people feel like they were sharing a meal with loved ones located in another city.
Pfizer’s COVID-19 vaccine 100% effective in adolescent study
Pfizer’s COVID-19 vaccine was reportedly 100% effective in a trial involving more than 2,000 adolescents between the ages of 12 and 15.
Research grants, the silicon valley way
In partnership with Stand Together
What if there was a way to fast-forward innovation? An economist and tech billionaire recently joined forces to make research grants available within 14 days.
A common virus may be the key to a COVID vaccine for young children
Researchers have reverse-engineered a common children’s virus to show the spike protein, potentially leading to a new COVID vaccine for young children.
DoorDash is now offering COVID-19 test delivery
DoorDash is now offering COVID-19 test delivery in 12 cities, bringing at-home COVID-19 test kits to people the same day they’re ordered.
A plant-based COVID vaccine is going into arms
A COVID-19 vaccine grown in plants is beginning phase 3 clinical trials.
Facebook’s vaccine hunters are helping Americans get vaccinated
COVID-19 shots are here, but making an appointment can be a pain. Vaccine hunters are playing matchmaker on Facebook to get jabs into arms.